| Product Code: ETC13056846 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import shipments of pediatric vaccines in India saw a significant shift in 2024, with top exporters being USA, Denmark, China, Sweden, and South Korea. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), increased from moderate to high in 2024, indicating a more consolidated market landscape. The compound annual growth rate (CAGR) for 2020-2024 was notably negative at -22.7%, with a steep decline in growth rate from 2023 to 2024 at -49.05%. These trends suggest a challenging environment for pediatric vaccine imports in India, potentially influenced by various factors impacting the market dynamics.

The India pediatric vaccine market is experiencing steady growth, driven by increasing awareness about the importance of immunization, government initiatives to expand vaccination coverage, and rising healthcare expenditure. Key players in the market include both domestic and multinational pharmaceutical companies offering a wide range of vaccines to prevent diseases such as measles, polio, hepatitis, and influenza among children. The introduction of new and improved vaccines, advancements in technology for vaccine development, and the implementation of national immunization programs are further propelling market growth. However, challenges such as vaccine hesitancy, inadequate infrastructure in rural areas, and affordability issues for certain vaccines remain significant barriers to achieving universal immunization coverage in India. Overall, the pediatric vaccine market in India presents opportunities for stakeholders to address these challenges and expand access to life-saving vaccines for children nationwide.
The India pediatric vaccine market is witnessing several key trends. One major trend is the increasing focus on improving immunization coverage rates across the country, leading to a growing demand for vaccines for diseases such as measles, polio, and pneumonia. Another trend is the introduction of new and advanced vaccines, including combination vaccines that offer protection against multiple diseases in a single shot, reducing the number of injections needed. Additionally, there is a rising awareness among parents and healthcare providers about the importance of vaccination in preventing childhood illnesses, driving the market growth. The government`s initiatives to expand immunization programs and the growing healthcare infrastructure in rural areas are also contributing to the market`s expansion. Overall, the India pediatric vaccine market is expected to continue growing steadily in the coming years.
The pediatric vaccine market in India faces several challenges, including inadequate awareness among parents regarding the importance of vaccination, lack of access to vaccines in rural areas, affordability issues for low-income families, and logistical challenges in maintaining the cold chain for storing vaccines. Additionally, there are regulatory hurdles and slow approval processes for introducing new vaccines in the market. The fragmented healthcare system and varying vaccine coverage across different states also contribute to the challenges faced by vaccine manufacturers and healthcare providers in effectively reaching and vaccinating children. Improving vaccination coverage rates, enhancing public awareness campaigns, investing in infrastructure for vaccine storage and distribution, streamlining approval processes, and addressing affordability issues are crucial steps needed to overcome these challenges in the Indian pediatric vaccine market.
The India pediatric vaccine market presents significant investment opportunities due to the increasing focus on child healthcare and government initiatives to expand immunization programs. With a large population and growing awareness about the importance of vaccination, there is a rising demand for pediatric vaccines in India. Investors can explore opportunities in manufacturing, distribution, and research & development of pediatric vaccines to cater to this growing market. Additionally, partnerships with healthcare providers, government bodies, and non-profit organizations can further enhance market penetration and access to this segment. Investing in innovative vaccine technologies, ensuring affordability and accessibility, and addressing healthcare disparities across different regions in India can also be key focus areas for investors looking to capitalize on the growth potential of the pediatric vaccine market in the country.
The Indian government has implemented various policies to promote vaccination coverage in the pediatric market. The Universal Immunization Program (UIP) provides free vaccines against several diseases, including tuberculosis, polio, measles, and hepatitis B, to children up to 16 years old. Additionally, the government has introduced the Mission Indradhanush program to accelerate the full immunization coverage by targeting underserved populations and increasing awareness about the importance of vaccines. The National Vaccine Policy emphasizes the need for research and development of new vaccines, promoting indigenous vaccine production, and ensuring quality and safety standards. The government also collaborates with international organizations like Gavi, the Vaccine Alliance, to access affordable vaccines and strengthen vaccination programs, ensuring a comprehensive approach to pediatric immunization in India.
The India pediatric vaccine market is poised for significant growth in the coming years due to several key factors. The increasing awareness about the importance of vaccines in preventing childhood diseases, coupled with government initiatives to expand immunization programs, will drive market demand. Additionally, the rising disposable income and improving healthcare infrastructure in India will make vaccines more accessible to a larger population. The introduction of new and advanced vaccines, along with ongoing research and development in the field of pediatric immunization, will further boost market growth. Overall, the India pediatric vaccine market is expected to experience steady expansion as more children receive essential vaccinations, leading to improved public health outcomes and reduced disease burden in the country.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Paediatric Vaccine Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Paediatric Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 India Paediatric Vaccine Market - Industry Life Cycle |
3.4 India Paediatric Vaccine Market - Porter's Five Forces |
3.5 India Paediatric Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Paediatric Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.7 India Paediatric Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 India Paediatric Vaccine Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 India Paediatric Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in children's health |
4.2.2 Government initiatives and programs to improve vaccination coverage |
4.2.3 Rising healthcare infrastructure and access to vaccines in rural areas |
4.3 Market Restraints |
4.3.1 High cost of vaccines and limited affordability among the population |
4.3.2 Lack of awareness and misconceptions about vaccines leading to hesitancy |
4.3.3 Challenges in vaccine distribution and logistics, especially in remote areas |
5 India Paediatric Vaccine Market Trends |
6 India Paediatric Vaccine Market, By Types |
6.1 India Paediatric Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Paediatric Vaccine Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 India Paediatric Vaccine Market Revenues & Volume, By Live Attenuated, 2021 - 2031F |
6.1.4 India Paediatric Vaccine Market Revenues & Volume, By Inactivated, 2021 - 2031F |
6.1.5 India Paediatric Vaccine Market Revenues & Volume, By Conjugate, 2021 - 2031F |
6.1.6 India Paediatric Vaccine Market Revenues & Volume, By Recombinant, 2021 - 2031F |
6.2 India Paediatric Vaccine Market, By Vaccine Type |
6.2.1 Overview and Analysis |
6.2.2 India Paediatric Vaccine Market Revenues & Volume, By MMR Vaccine, 2021 - 2031F |
6.2.3 India Paediatric Vaccine Market Revenues & Volume, By Polio Vaccine, 2021 - 2031F |
6.2.4 India Paediatric Vaccine Market Revenues & Volume, By Pneumococcal, 2021 - 2031F |
6.2.5 India Paediatric Vaccine Market Revenues & Volume, By Hepatitis B, 2021 - 2031F |
6.3 India Paediatric Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 India Paediatric Vaccine Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.3.3 India Paediatric Vaccine Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.3.4 India Paediatric Vaccine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.5 India Paediatric Vaccine Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.4 India Paediatric Vaccine Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 India Paediatric Vaccine Market Revenues & Volume, By Infants, 2021 - 2031F |
6.4.3 India Paediatric Vaccine Market Revenues & Volume, By Toddlers, 2021 - 2031F |
6.4.4 India Paediatric Vaccine Market Revenues & Volume, By Adolescents, 2021 - 2031F |
6.4.5 India Paediatric Vaccine Market Revenues & Volume, By Newborns, 2021 - 2031F |
7 India Paediatric Vaccine Market Import-Export Trade Statistics |
7.1 India Paediatric Vaccine Market Export to Major Countries |
7.2 India Paediatric Vaccine Market Imports from Major Countries |
8 India Paediatric Vaccine Market Key Performance Indicators |
8.1 Percentage of children vaccinated as per recommended schedule |
8.2 Number of vaccination camps or outreach programs conducted |
8.3 Vaccine wastage rate |
8.4 Adverse events following immunization (AEFI) reporting rate |
8.5 Vaccine coverage in underserved or remote areas |
9 India Paediatric Vaccine Market - Opportunity Assessment |
9.1 India Paediatric Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Paediatric Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.3 India Paediatric Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 India Paediatric Vaccine Market Opportunity Assessment, By Application, 2021 & 2031F |
10 India Paediatric Vaccine Market - Competitive Landscape |
10.1 India Paediatric Vaccine Market Revenue Share, By Companies, 2024 |
10.2 India Paediatric Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here